Form D Explorer
Pheast Therapeutics, Inc. · CIK 1943737

Report a data issueCitable research briefCompare issuerPrivate research collection

Pheast Therapeutics, Inc.

CIK 1943737 · Corporation · Inc. DELAWARE · REDWOOD CITY, California · Other Technology
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
1
Amendments
1
Activity
Apr 10, 2025
through Oct 16, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 10, 2025 · D/AOct 16, 2025 · DLater minus earlier
Reported offering amount$75,250,000$39,999,993$-35,250,007
Reported amount sold$75,250,000$24,588,083$-50,661,917
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001943737-25-000001 · Later SEC source: 0001231919-25-000321

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Oct 16, 2025

Reported offering amount
$39,999,993
Reported exemptions
Rule 506(b)
Reported amount sold
$24,588,083

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)